$68.11
0.82% yesterday
Nasdaq, Dec 16, 10:19 pm CET
ISIN
US88023B1035
Symbol
TEM

Tempus AI Stock News

Neutral
The Motley Fool
about one month ago
Cathie Wood added to her stakes in Circle Internet Group, Bitmine Immersion, and Tempus AI on Thursday. The three stocks fell as much as 10% on Thursday, giving Ark Invest a chance to add on a dip.
Neutral
Business Wire
about one month ago
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new research study sponsored by Tempus and being run in collaboration with the Institute for Follicular Lymphoma Innovation (IFLI), a global, nonprofit, private foundation dedicated to accelerating the development of innovative treatment optio...
Neutral
Seeking Alpha
about one month ago
Tempus AI, Inc. ( TEM ) Stifel 2025 Healthcare Conference November 13, 2025 10:00 AM EST Company Participants James Rogers - Chief Financial Officer Conference Call Participants Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Daniel Arias Stifel, Nicolaus & Company, Incorporated, Research Division Okay. Welcome back, everyone, to the 2025 Stifel Healthcar...
Positive
Seeking Alpha
about one month ago
Tempus AI stands out as a leader in healthcare AI, showing strong execution and robust Q3 results despite recent stock volatility. TEM reported 85% revenue growth, expanding gross margins, and solid performance in both Genomics and Data/Services segments, with high visibility into future growth. The recent stock pullback, driven by high expectations, presents an attractive entry point for long-...
Positive
Seeking Alpha
about one month ago
Tempus AI remains a buy as its data set, testing volumes, and financial results continue to show robust growth. TEM's Genomics segment drives strong revenue growth, with oncology and hereditary testing volumes rising significantly year-over-year. Gross margin expansion, narrowing losses, and a solid cash position highlight TEM's improving profitability and financial health.
Positive
Seeking Alpha
about one month ago
Tempus AI is building a strong moat in healthcare AI with vast clinical/genomic datasets and robust infrastructure, driving high-growth potential. TEM achieved its first positive adjusted EBITDA in Q3, signaling improved operational leverage, though GAAP EBITDA remains negative due to adjustments. Despite rapid revenue growth and expanding total addressable market, TEM's high market cap and ong...
Neutral
The Motley Fool
about one month ago
Cathie Wood added to her stakes in Archer Aviation, DoorDash, and Tempus AI on Thursday. Archer Aviation is trading lower this year as it ramps up its fleet for high-end short-range air travel.
Positive
MarketBeat
about one month ago
Tempus AI's NASDAQ: TEM stock price pulled back in early November following its Q3 release, aligning with broader market action and opening a buying opportunity for investors. The primary concern is the valuation, which is admittedly high relative to its current-year outlook.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today